StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ALRPD.PA$8.60+9.74%
Fair $8.60+0.0%

ALRPD.PA

Rapid Nutrition PLC

Consumer Defensive / Packaged FoodsParis

$8.60

+0.71 (+9.74%)

Fairly Valued+0.0%Fair Value $8.60Fund rank 28/100 · Data gapFallback financials|
SA 26/D
F-Score: 2/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-3.0M · quality 52.3/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 3 consecutive years ROE is -36.4%, below the 5% threshold
Thesis & Journal · ALRPD.PALocal privado en este navegador · Rapid Nutrition PLC
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-36.4%

↓

Gross Margin

27.2%

↓

Debt/Equity

0.01

↓
52-Week Range$9
$2$23

TradingView lightweight chart

ALRPD.PA price, volumen y niveles de valoración

Último $8.000Periodo -100.0%
Fair value: $8.600

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-59.5%

FCF CAGR

—

FCF margin

-1607.9%

FCF / Net income

1.01x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $194326.0 · net income $-3.1M · FCF $-3.1M

2022-FY → 2025-FY

Gross margin

27.2%-43.9% pts

Operating margin

-1353.9%-1052.7% pts

Net margin

-1596.1%-1254.6% pts

FCF margin

-1607.9%-1563.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$194326.00$194326.00$917044.00$1.7M$2.9M
Net Income$-3.1M$-3.1M$-3.0M$-2.2M$-10.0M
EBITDA$-2.6M$-2.6M$-1.6M$-1.9M$-8.8M
EPS-10.00-10.00-94.90-1100.00-1800.00
Gross Margin27.2%27.2%52.6%49.4%71.1%
Operating Margin-1353.9%-1353.9%-178.6%-124.2%-301.3%
Net Margin-1596.1%-1596.1%-328.2%-130.2%-341.5%
Balance Sheet
Debt/Equity0.010.01-0.65-0.543.30
Current Ratio18.6818.68———
Cash Flow
Free Cash Flow$-3.1M$-3.1M$-3.0M$-1.6M$-1.3M
Returns
ROE-36.4%-36.4%2079.6%566.9%-9237.9%
Valuation
P/B0.310.31——178.24
Growth & Yield
Revenue Growth-78.8%-78.8%-44.6%-43.3%—
EPS Growth89.5%89.5%91.4%38.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +116.2%

Total return

+116.2%

Start / end P/E

n/dx → n/dx

EPS bridge

-94.90 → -10.00

Residual

+116.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+116.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.